{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T07:11:31Z","timestamp":1772608291038,"version":"3.50.1"},"reference-count":76,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Elisabeth and Alfred Ahlqvist Foundation"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","europeanneuropsychopharmacology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.euroneuro.2016.07.004","type":"journal-article","created":{"date-parts":[[2016,7,27]],"date-time":"2016-07-27T21:37:24Z","timestamp":1469655444000},"page":"1401-1411","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Alpha7 nicotinic acetylcholine receptor agonists and PAMs as adjunctive treatment in schizophrenia. An experimental study"],"prefix":"10.1016","volume":"26","author":[{"given":"Monica M.","family":"Marcus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl","family":"Bj\u00f6rkholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Malmerfelt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annie","family":"M\u00f6ller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ninni","family":"P\u00e5hlsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c5sa","family":"Konradsson-Geuken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin","family":"Feltmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kent","family":"Jardemark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bj\u00f6rn","family":"Schilstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torgny H.","family":"Svensson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2016.07.004_bib1","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0006-3223(92)90073-9","article-title":"Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics","volume":"32","author":"Adler","year":"1992","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.07.004_bib2","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1177\/0269881110364271","article-title":"Subtype-selective nicotinic acetylcholine receptor agonists enhance the responsiveness to citalopram and reboxetine in the mouse forced swim test","volume":"25","author":"Andreasen","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2016.07.004_bib3","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0022-3565(24)37013-2","article-title":"Clozapine and haloperidol modulate N-methyl-D-aspartate- and non-N-methyl-D-aspartate receptor-mediated neurotransmission in rat prefrontal cortical neurons in vitro","volume":"283","author":"Arvanov","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2016.07.004_bib4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0091-3057(00)00205-7","article-title":"The effects of nicotine on neural pathways implicated in depression: a factor in nicotine addiction?","volume":"66","author":"Balfour","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.euroneuro.2016.07.004_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-012-2933-4","article-title":"Pharmacological and behavioral profile of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]\u22126-chinolincarboxamide (EVP-5141), a novel alpha7 nicotinic acetylcholine receptor agonist\/serotonin 5-HT3 receptor antagonist","volume":"227","author":"Boess","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2016.07.004_bib6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.neuroscience.2013.09.047","article-title":"Localized infusions of the partial alpha 7 nicotinic receptor agonist SSR180711 evoke rapid and transient increases in prefrontal glutamate release","volume":"255","author":"Bortz","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.euroneuro.2016.07.004_bib7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.biopsych.2010.08.006","article-title":"Immediate and sustained improvements in working memory after selective stimulation of alpha7 nicotinic acetylcholine receptors","volume":"69","author":"Castner","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.07.004_bib8","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/j.1471-4159.2010.06845.x","article-title":"Repeated administration of alpha7 nicotinic acetylcholine receptor (nAChR) agonists, but not positive allosteric modulators, increases alpha7 nAChR levels in the brain","volume":"114","author":"Christensen","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.euroneuro.2016.07.004_bib9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1176\/ajp.154.2.263","article-title":"Major depression following smoking cessation","volume":"154","author":"Covey","year":"1997","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.07.004_bib10","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF02245592","article-title":"Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants","volume":"121","author":"Detke","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2016.07.004_bib11","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.schres.2013.05.023","article-title":"Targeting alpha-7 nicotinic neurotransmission in schizophrenia: a novel agonist strategy","volume":"148","author":"Deutsch","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2016.07.004_bib12","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1176\/appi.ps.201200143","article-title":"Cigarette smoking among persons with schizophrenia or bipolar disorder in routine clinical settings, 1999\u20132011","volume":"64","author":"Dickerson","year":"2013","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.euroneuro.2016.07.004_bib13","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.biopsych.2005.03.038","article-title":"Enhanced cortical dopamine output and antipsychotic-like effect of raclopride with adjunctive low-dose L-dopa","volume":"58","author":"Eltayb","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.07.004_bib14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0166-4328(88)90157-X","article-title":"A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data","volume":"31","author":"Ennaceur","year":"1988","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.euroneuro.2016.07.004_bib15","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.biopsych.2007.07.016","article-title":"Regionally specific regulation of ERK MAP kinase in a model of antidepressant-sensitive chronic depression","volume":"63","author":"Gourley","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.07.004_bib17","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.bbr.2014.10.025","article-title":"Assessment of disease-related cognitive impairments using the novel object recognition (NOR) task in rodents","volume":"285","author":"Grayson","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.euroneuro.2016.07.004_bib18","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1124\/mol.107.035410","article-title":"Distinct profiles of alpha7 nAChR positive allosteric modulation revealed by structurally diverse chemotypes","volume":"72","author":"Gronlien","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.euroneuro.2016.07.004_bib19","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1124\/jpet.104.076968","article-title":"The selective alpha7 nicotinic acetylcholine receptor agonist PNU-282987 [N-[(3R)\u22121-Azabicyclo[2.2.2]oct-3-yl]\u22124-chlorobenzamide hydrochloride] enhances GABAergic synaptic activity in brain slices and restores auditory gating deficits in anesthetized rats","volume":"312","author":"Hajos","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2016.07.004_bib20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1126\/science.286.5437.105","article-title":"Enhanced cortical dopamine output and antipsychotic-like effects of raclopride by alpha2 adrenoceptor blockade","volume":"286","author":"Hertel","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.euroneuro.2016.07.004_bib21","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1007\/s00213-014-3596-0","article-title":"The novel alpha7 nicotinic acetylcholine receptor agonist EVP-6124 enhances dopamine, acetylcholine, and glutamate efflux in rat cortex and nucleus accumbens","volume":"231","author":"Huang","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2016.07.004_bib22","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0893-133X(01)00312-8","article-title":"Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum","volume":"26","author":"Ichikawa","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2016.07.004_bib23","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00213-011-2554-3","article-title":"Differential effects of AMPA receptor potentiators and glycine reuptake inhibitors on antipsychotic efficacy and prefrontal glutamatergic transmission","volume":"221","author":"Jardemark","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2016.07.004_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0306-4522(00)00253-0","article-title":"Subchronic treatment with either clozapine, olanzapine or haloperidol produces a hyposensitive response of the rat cortical cells to N-methyl-D-aspartate","volume":"100","author":"Jardemark","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.euroneuro.2016.07.004_bib25","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/npp.2011.199","article-title":"Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia","volume":"37","author":"Jones","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2016.07.004_bib26","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00213-013-3275-6","article-title":"Effect of alpha7 nicotinic acetylcholine receptor agonists on attentional set-shifting impairment in rats","volume":"231","author":"Jones","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2016.07.004_bib27","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejphar.2010.08.023","article-title":"Effects of reboxetine and citalopram pretreatment on changes in cocaine and amphetamine regulated transcript (CART) expression in rat brain induced by the forced swimming test","volume":"647","author":"Kang","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2016.07.004_bib28","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1124\/jpet.102.046987","article-title":"Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy","volume":"305","author":"Kapur","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2016.07.004_bib30","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/syn.20286","article-title":"Inhibition of the glycine transporter GlyT-1 potentiates the effect of risperidone, but not clozapine, on glutamatergic transmission in the rat medial prefrontal cortex","volume":"60","author":"Konradsson","year":"2006","journal-title":"Synapse"},{"key":"10.1016\/j.euroneuro.2016.07.004_bib31","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/syn.20693","article-title":"Second-by-second analysis of alpha 7 nicotine receptor regulation of glutamate release in the prefrontal cortex of awake rats","volume":"63","author":"Konradsson-Geuken","year":"2009","journal-title":"Synapse"},{"key":"10.1016\/j.euroneuro.2016.07.004_bib32","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/00008877-199911000-00014","article-title":"AR-R17779, and alpha7 nicotinic agonist, improves learning and memory in rats","volume":"10","author":"Levin","year":"1999","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.euroneuro.2016.07.004_bib33","series-title":"Change-Over Design. Introduction to Experimental Statistics","first-page":"207","author":"Li","year":"1964"},{"key":"10.1016\/j.euroneuro.2016.07.004_bib34","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1084\/jem.20121270","article-title":"The alpha7nACh-NMDA receptor complex is involved in cue-induced reinstatement of nicotine seeking","volume":"209","author":"Li","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.euroneuro.2016.07.004_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-6606-6-58","article-title":"Alpha7nAchR\/NMDAR coupling affects NMDAR function and object recognition","volume":"6","author":"Li","year":"2013","journal-title":"Mol. Brain"},{"key":"10.1016\/j.euroneuro.2016.07.004_bib36","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/npp.2012.259","article-title":"A randomized exploratory trial of an alpha-7 nicotinic receptor agonist (TC-5619) for cognitive enhancement in schizophrenia","volume":"38","author":"Lieberman","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2016.07.004_bib37","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1460-9568.2009.06613.x","article-title":"Alpha7 and non-alpha7 nicotinic acetylcholine receptors modulate dopamine release in vitro and in vivo in the rat prefrontal cortex","volume":"29","author":"Livingstone","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.euroneuro.2016.07.004_bib38","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00213-011-2536-5","article-title":"Spontaneous object recognition and its relevance to schizophrenia: a review of findings from pharmacological, genetic, lesion and developmental rodent models","volume":"220","author":"Lyon","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2016.07.004_bib39","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1017\/S1461145705005328","article-title":"Combined alpha2 and D2\/3 receptor blockade enhances cortical glutamatergic transmission and reverses cognitive impairment in the rat","volume":"8","author":"Marcus","year":"2005","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2016.07.004_bib40","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/syn.21510","article-title":"Augmentation by escitalopram, but not citalopram or R-citalopram, of the effects of low-dose risperidone: behavioral, biochemical, and electrophysiological evidence","volume":"66","author":"Marcus","year":"2012","journal-title":"Synapse"},{"key":"10.1016\/j.euroneuro.2016.07.004_bib41","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1017\/S1461145709990794","article-title":"Adjunctive alpha2-adrenoceptor blockade enhances the antipsychotic-like effect of risperidone and facilitates cortical dopaminergic and glutamatergic, NMDA receptor-mediated transmission","volume":"13","author":"Marcus","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2016.07.004_bib42","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00213-011-2357-6","article-title":"Preclinical assessment of an adjunctive treatment approach for cognitive impairment associated with schizophrenia using the alpha7 nicotinic acetylcholine receptor agonist WYE-103914\/SEN34625","volume":"218","author":"Marquis","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2016.07.004_bib44","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.neuropharm.2012.05.020","article-title":"Noradrenergic antidepressants increase cortical dopamine: potential use in augmentation strategies","volume":"63","author":"Masana","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2016.07.004_bib45","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00213-009-1578-4","article-title":"Effect of sertindole on extracellular dopamine, acetylcholine, and glutamate in the medial prefrontal cortex of conscious rats: a comparison with risperidone and exploration of mechanisms involved","volume":"206","author":"M\u00f8rk","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2016.07.004_bib46","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0304-3940(93)90641-W","article-title":"Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studied in vivo","volume":"157","author":"Murase","year":"1993","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.euroneuro.2016.07.004_bib47","doi-asserted-by":"crossref","first-page":"8059","DOI":"10.1073\/pnas.0701321104","article-title":"Nootropic alpha7 nicotinic receptor allosteric modulator derived from GABAA receptor modulators","volume":"104","author":"Ng","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.euroneuro.2016.07.004_bib48","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.euroneuro.2015.04.018","article-title":"Positive allosteric modulation of alpha 7 nicotinic acetylcholine receptors enhances recognition memory and cognitive flexibility in rats","volume":"25","author":"Nikiforuk","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2016.07.004_bib49","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.neuropharm.2015.07.034","article-title":"Positive allosteric modulators of alpha 7 nicotinic acetylcholine receptors reverse ketamine-induced schizophrenia-like deficits in rats","volume":"101","author":"Nikiforuk","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2016.07.004_bib50","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0166-4328(00)00204-7","article-title":"Role of alpha7 nicotinic receptors in nicotine dependence and implications for psychiatric illness","volume":"113","author":"Nomikos","year":"2000","journal-title":"Behav. Brain Res"},{"key":"10.1016\/j.euroneuro.2016.07.004_bib51","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1191\/0960327106ht611oa","article-title":"The influence of tobacco smoke and nicotine on antidepressant and memory-improving effects of venlafaxine","volume":"25","author":"Nowakowska","year":"2006","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.euroneuro.2016.07.004_bib52","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1998"},{"key":"10.1016\/j.euroneuro.2016.07.004_bib53","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/sj.npp.1301188","article-title":"SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia","volume":"32","author":"Pichat","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2016.07.004_bib54","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","article-title":"Depression: a new animal model sensitive to antidepressant treatments","volume":"266","author":"Porsolt","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.euroneuro.2016.07.004_bib55","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/01.pra.0000442935.15833.c5","article-title":"Normalizing effects of EVP-6124, an alpha-7 nicotinic partial agonist, on event-related potentials and cognition: a proof of concept, randomized trial in patients with schizophrenia","volume":"20","author":"Preskorn","year":"2014","journal-title":"J. Psychiatr. Pract."},{"key":"10.1016\/j.euroneuro.2016.07.004_bib56","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s00018-013-1481-3","article-title":"Nicotinic acetylcholine receptors in attention circuitry: the role of layer VI neurons of prefrontal cortex","volume":"71","author":"Proulx","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.euroneuro.2016.07.004_bib57","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2165\/11530260-000000000-00000","article-title":"Cholinesterase inhibitors as adjunctive therapy in patients with schizophrenia and schizoaffective disorder: a review and meta-analysis of the literature","volume":"24","author":"Ribeiz","year":"2010","journal-title":"CNS Drugs"},{"key":"10.1016\/j.euroneuro.2016.07.004_bib58","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/sj.npp.1301087","article-title":"Galantamine enhances dopaminergic neurotransmission in vivo via allosteric potentiation of nicotinic acetylcholine receptors","volume":"32","author":"Schilstr\u00f6m","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2016.07.004_bib59","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/syn.20853","article-title":"Effects of S-citalopram, citalopram and R-citalopram on the firing patterns of dopamine neurons in the ventral tegmental area, NMDA receptor-mediated transmission in the medial prefrontal cortex and cognitive function in the rat","volume":"65","author":"Schilstr\u00f6m","year":"2011","journal-title":"Synapse"},{"key":"10.1016\/j.euroneuro.2016.07.004_bib91","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1073\/pnas.0505557103","article-title":"Allosteric changes of the NMDA receptor trap diffusible dopamine 1 receptor in spines","volume":"103","author":"Scott","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.euroneuro.2016.07.004_bib60","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.biopsych.2006.04.006","article-title":"Galantamine improves cognition in schizophrenic patients stabilized on risperidone","volume":"60","author":"Schubert","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.07.004_bib61","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0920-9964(99)00138-3","article-title":"Xanomeline, an M(1)\/M(4) preferring muscarinic cholinergic receptor agonist, produces antipsychotic-like activity in rats and mice","volume":"42","author":"Shannon","year":"2000","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2016.07.004_bib62","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1016\/j.bmcl.2012.03.062","article-title":"The discovery of 2-fluoro-N-(3-fluoro-4-(5-((4-morpholinobutyl)amino)\u22121,3,4-oxadiazol-2-yl)phenyl) benzamide, a full agonist of the alpha-7 nicotinic acetylcholine receptor showing efficacy in the novel object recognition model of cognition enhancement","volume":"22","author":"Skidmore","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.euroneuro.2016.07.004_bib63","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0893-133X(02)00324-X","article-title":"Effects of cigarette smoking and nicotine nasal spray on psychiatric symptoms and cognition in schizophrenia","volume":"27","author":"Smith","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2016.07.004_bib64","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s002130050573","article-title":"Selective alpha7-nicotinic agonists normalize inhibition of auditory response in DBA mice","volume":"136","author":"Stevens","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2016.07.004_bib65","doi-asserted-by":"crossref","unstructured":"Svensson, T.H., Grenhoff, J., Engberg, G., 1990. Effect of nicotine on dynamic function of brain catecholamine neurons. In: Proceedings of the Ciba Foundation Symposium 1. editor. The biology of nicotine dependence. Chicester: John Wiley & Sons. pp. 169\u2013185.","DOI":"10.1002\/9780470513965.ch10"},{"key":"10.1016\/j.euroneuro.2016.07.004_bib66","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.bcp.2009.07.005","article-title":"Selective alpha7 nicotinic receptor activation by AZD0328 enhances cortical dopamine release and improves learning and attentional processes","volume":"78","author":"Sydserff","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.euroneuro.2016.07.004_bib67","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.neulet.2014.03.067","article-title":"Antidepressant activity in mice elicited by 3-furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the \u03b17 nicotinic acetylcholine receptor","volume":"569","author":"Targowska-Duda","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.euroneuro.2016.07.004_bib68","doi-asserted-by":"crossref","first-page":"e27014","DOI":"10.1371\/journal.pone.0027014","article-title":"Differential immediate and sustained memory enhancing effects of alpha7 nicotinic receptor agonists and allosteric modulators in rats","volume":"6","author":"Thomsen","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.euroneuro.2016.07.004_bib69","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1755-5949.2008.00037.x","article-title":"Preclinical characterization of A-582941: a novel alpha7 neuronal nicotinic receptor agonist with broad spectrum cognition-enhancing properties","volume":"14","author":"Tietje","year":"2008","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.euroneuro.2016.07.004_bib70","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1124\/jpet.107.120436","article-title":"An allosteric modulator of the alpha7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivo","volume":"323","author":"Timmermann","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2016.07.004_bib71","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2174\/138161210790170085","article-title":"Conditioned avoidance response in the development of new antipsychotics","volume":"16","author":"Wadenberg","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.euroneuro.2016.07.004_bib72","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0006-3223(90)90657-N","article-title":"Suppression of conditioned avoidance behavior by the local application of (\u2212)sulpiride into the ventral, but not the dorsal, striatum of the rat","volume":"28","author":"Wadenberg","year":"1990","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.07.004_bib73","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0893-133X(01)00261-5","article-title":"Dopamine d(2) receptor occupancy is a common mechanism underlying animal models of antipsychotics and their clinical effects","volume":"25","author":"Wadenberg","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2016.07.004_bib75","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1017\/S1461145708008730","article-title":"Adjunctive galantamine, but not donepezil, enhances the antipsychotic-like effect of raclopride in rats","volume":"11","author":"Wiker","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2016.07.004_bib76","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.bcp.2011.05.001","article-title":"Positive allosteric modulators as an approach to nicotinic acetylcholine receptor-targeted therapeutics: advantages and limitations","volume":"82","author":"Williams","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.euroneuro.2016.07.004_bib77","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/YCO.0b013e3283366643","article-title":"Why do patients with schizophrenia smoke?","volume":"23","author":"Winterer","year":"2010","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.07.004_bib78","doi-asserted-by":"crossref","first-page":"12078","DOI":"10.1073\/pnas.1307849110","article-title":"Nicotinic alpha7 receptors enhance NMDA cognitive circuits in dorsolateral prefrontal cortex","volume":"110","author":"Yang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.euroneuro.2016.07.004_bib79","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.bcp.2013.06.031","article-title":"Evaluating the role of the alpha-7 nicotinic acetylcholine receptor in the pathophysiology and treatment of schizophrenia","volume":"86","author":"Young","year":"2013","journal-title":"Biochem. Pharmacol."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X1630102X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X1630102X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T06:37:38Z","timestamp":1749019058000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X1630102X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":76,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0924977X1630102X"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2016.07.004","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alpha7 nicotinic acetylcholine receptor agonists and PAMs as adjunctive treatment in schizophrenia. An experimental study","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2016.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}